Submit Entry | Bio-IT World Conference & Expo | Sponsorship
Download the 2013 Best Practices Compendium
Bio-IT World Best Practices Awards
Early Deadline December 16, 2013 (no application fee) | Advanced Deadline February 10, 2014
Celebrating Excellence in Innovation
The 2014 Bio-IT World Best Practices competition has released its call for entries. The final deadline for entry is February 10, 2014.
Bio-IT World has held the Best Practices awards since 2003, highlighting outstanding examples of technology innovation in the life sciences, from basic R&D to translational medicine. We particularly encourage vendors to nominate entries from valued academic and/or industry partners.
Submitting your organization’s entry is straightforward:
• Send us a brief overview of your technology, including a statement of the issue or problem at hand, the innovative approach or technology applied, and the ROI (Return on Investment) in terms of scientific insights, cost savings, productivity, etc. (entry form and full details here)
• Entries will be accepted until February 10, 2014. (if received by December 16, there is no application fee)
• All entries will be judged by an expert panel in February/March 2014.
• Winners will be announced in a plenary session at Bio-IT World Conference & Expo, Boston, April 29- May 1, 2014.
• All winners will be featured in follow-up profiles in Bio-IT World.
Please send entries or direct any questions to Bio-IT World Managing Editor, Allison Proffitt.
The 2013 Bio-IT World Best Practice Winners were announced at the 2013 Bio-IT World Conference & Expo, World Trade Center in Boston, MA, USA.
Knowledge Management: GlaxoSmithKline (Read News Story)
Socrates Search is a new program that can search through the company’s archived electronic lab notebooks and recognize a vast library of scientific terms, bringing once inaccessible data to scientists’ fingertips.
Judges’ Prize: Genentech (Read News Story)
A recent innovation in Genentech’s mouse cage changing procedure showcased the savings that can be achieved when waste is tackled aggressively, The system saved Genentech a staggering $411,000 a year.
Clinical and Health IT: Prize4Life and the Neurological Clinical Research Institute (NCRI) at Massachusetts General Hospital (Read News Story)Amyotrophic lateral sclerosis (ALS) research is getting a major boost from a newly launched Pooled Resource Open-access ALS Clinical Trials (PRO-ACT) platform, which has amassed more than 8,500 de-identified clinical patient records into a single, harmonized dataset.
Informatics: Genomic Medicine Institute, Geisinger Health System (Read News Story)
(Nominated by SimulConsult) Geisinger Health System tested SimulConsult’s “Genome-Phenome Analyzer,” which combines a patient’s sequenced genome with the physician’s clinical findings to help determine a diagnosis. The program calculates the severity of thousands of genetic variants, based on peer-reviewed genetic articles, and correlates the relevant variants with the patient’s signs and symptoms. The result is a differential diagnosis ranked by the likelihood that each disease is the culprit.
IT Infrastructure/HPC: Schrodinger (Read News Story)
(Nominated by Cycle Computing) The Cloud’s the Limit: Rentable Supercomputers for Improving Drug Discovery
Schrodinger and Cycle Computing tested Glide’s docking algorithms by screening a staggering 21 million small molecule ligands against a protein target on a 50,000 core cloud-based supercomputer on the Amazon cloud. Cycle Computing provided Schrodinger with the computational power their program required in three hours.
Editors’ Prize: GeneInsight (Read News Story)
Partners Healthcare Center for Personalized Genetic Medicine (PCPGM) in Boston has been using GeneInsight for over eight years and has generated 30,000 reports. The platform consists of a clinician-facing application that can be integrated with electronic health records or stand alone, and a laboratory-focused application that manages knowledge, and facilitates reporting.
JBI and Amgen (Read News Story)
(Nominated by TeselaGen Biotechnology)
Immune Tolerance Network
(Nominated by LabKey Software)TrialShare Brings Much Needed Transparency to Clinical Trials Data
Through TrialShare, a simple-to-use clinical trials research web portal developed at the Immune Tolerance Network, investigators and study management teams can better interpret data throughout the clinical trials process. Built using the open source LabKey Server framework, TrialShare provides open access to ITN’s clinical studies, its datasets, and bio-repository to the scientific community.
As a supporter, your sponsorship of the Best Practices Awards Program offers extensive exposure to Bio-IT World audiences, positions your company as a thought-leader in the life science market, and gives you preferred access to the best and brightest thinkers in the life science community. Support this worthwhile industry program through one of our many sponsorship packages.
Testimonials | Photo Gallery | Download the 2013 Best Practices Compendium